{"prompt": "['APPROVED RPCI IRB', '3/22/2021', 'Roswell Park Protocol No.: I 33616', 'IN-TEXT TABLES', 'Table 1.', 'Response to Therapy for SCC', '16', 'Table 2', 'Schedule of Procedures and Observations for Participants Randomized to PDT', '30', 'Table 3', 'Schedule of Procedures and Observations for Participants Randomized to Surgery 32', 'Table 4', 'Time Point Response Criteria (+/- non-target disease)', '36', 'Table 5', 'Guidelines for Routine Adverse Event Reporting for Phase 2 Studies (Regardless of', 'Expectedness)', '39', 'PRIVATE AND CONFIDENTIAL INFORMATION OF ROSWELL PARK CANCER INSTITUTE', '01-14-21', 'Page 10 of 64']['APPROVED RPCI IRB', '3/22/2021', 'Roswell Park Protocol No.: I 33616', 'APPENDICES', 'Appendix A.', 'Instructions for Network Sites', '48', 'Appendix B.', 'Spectroscopy', '51', 'Appendix C', 'Chemical Sterilization', '52', 'Appendix D', 'ECOG Performance Status', '53', 'Appendix E', 'Toxicity Serious Adverse Event Reports', '54', 'Appendix F', 'Normal Tissue Toxicity Grading', '55', 'Appendix G.', 'Correlative Studies (if possible)', '56', 'Appendix H', 'Appendix H. University of Washington Quality of Life Questionnaire version 4', '(UW-QoLQV4)', '57', 'PRIVATE AND CONFIDENTIAL INFORMATION OF ROSWELL PARK CANCER INSTITUTE', '01-14-21', 'Page 11 of 64']['APPROVED RPCI IRB', '3/22/2021', 'Roswell Park Protocol No.: I 33616', '1', 'BACKGROUND', '1.1 CANCER OF THE ORAL CAVITY', 'Cancer of the head and neck is the sixth most prevalent cancer worldwide, with an incidence', 'exceeding half a million cases annually. 1 The most recent data from the NCI Surveillance,', 'Epidemiology, and End Results (SEER) Program predicted that 48,330 men and women (34,780', 'men and 13,550 women) would be diagnosed with and 9,750 men and women would die of cancer', 'of the oral cavity and pharynx in 2016.\u00b2 These numbers represent an estimated 16.8% increase in', 'the incident and 23.57% in death rate when compared to the published statistics in 2013', '(41,380 were diagnosed and 7,890 were expected to die from head and neck cancer). 3 The steady', 'increase in incidents and death rate suggest that there is an urgent need to improve the treatment', 'for this specific cancer.', '1.2', 'STANDARD TREATMENT FOR EARLY STAGE CANCER OF THE ORAL', 'CAVITY', 'Surgery and radiotherapy are standard treatment modalities for T1/T2 oral cavity cancer (OCC).4', 'Several studies demonstrated that surgery is the preferred treatment for oral squamous cell', 'carcinoma (SCC), yielding superior 5-year survival rates when compared to radiation therapy.4,5', 'Furthermore, the sequelae of radiation therapy such as xerostomia, chronic dental decay and risk', 'of mandibular osteonecrosis remain long after the patient is \"cured,\" reducing the patients\\' quality', 'of life (QoL).', 'Effective surgical treatment of OCC requires wide local resection of the primary tumor with clear', 'surgical margins. In order to secure tumor free margins the surgical procedures remove additional', 'functional tissue often affecting speech and swallowing. Following the initial surgery, the risk', 'of local recurrences is as high as 20%.7-9 Local recurrences are usually treated with further', 'surgery, requiring more mucosal resection. Patients that have been cured with standard therapy', 'also have a significant risk of developing second primary tumors, which has been associated with', 'poor prognosis. 10-12 Treatment of second primaries will increase patient morbidity. Currently,', 'younger patients are being diagnosed with oral cancer, and their QoL is severely affected by', 'standard of care therapies. 6,13 It is important to provide this patient population with a first line', 'therapy that will not cause irreversible long-term toxicities, and if failed, can be followed with', 'standard surgery to improve the chance of cure.', 'Photodynamic therapy (PDT) can result in good local control of early stage OCC with minimal', 'loss of tissue volume and excellent long-term healing that is expected to improve QoL. 14-16 Our', 'experience (including our collaborator, Dr. Biel) suggest that patients who failed to respond to', 'PDT can be safely salvaged with standard surgery. 17,18', '1.3 PHOTODYNAMIC THERAPY FOR EARLY STAGE HEAD AND NECK', 'CANCER', 'Numerous studies over the past 25 years have used photodynamic therapy (PDT) to treat early', 'stage oral and oropharyngeal carcinomas. While many of the early studies were single site with', 'small numbers of patients, in 2004 a major prospective multi-center trial was conducted', 'using', 'mTHPC-PDT to treat early (carcinoma in situ, Cis -T2) disease.19 A total of 114 patients were', 'PRIVATE AND CONFIDENTIAL INFORMATION OF ROSWELL PARK CANCER INSTITUTE', '01-14-21', 'Page 12 of 64']\n\n###\n\n", "completion": "END"}